Have a question or want to speak with a team member?
Stay updated on our progress in changing the landscape of ovarian cancer treatment options and outcomes.
May 27, 2020
Paving the way for research breakthroughs
Allen Zhang receives 2020 Anita Unruh Prize
Nov 27, 2019
Getting to Know Alicia Tone, Scientific Advisor
While advancing research and treatment options for women diagnosed or at risk of the disease is a critical priority, exploring and informing women about disease prevention is also important to us.
Sep 26, 2019
PARP Inhibitors 101 – New hope for the treatment of ovarian cancer
PARP inhibitors (PARPi) are a new family of drugs being used in the treatment of ovarian cancer.
Mar 19, 2019
Mar 19, 2019
Press Release – Budget 2019
Ovarian Cancer Canada Welcomes Long-Sought Investments in Research Funding
Sep 19, 2018
McGill researcher receives the Pat McDonald Research Award
Little is known about how high-grade serous ovarian cancer develops. But that’s set to change, if Dr. Yojiro Yamanaka has anything to say about it.
Jun 26, 2018
Conference brings together women with ovarian cancer and researchers
As scientists, research trainees, and specialists gathered in Edmonton for the Canadian Conference on Ovarian Cancer Research, women and their families came from near and far to attend a concurrent workshop focused on survivorship.
Mar 20, 2018
Researcher aims to continue one woman’s legacy
Yikan Wang receives the inaugural Anita Unruh Prize
Feb 22, 2018
Examining evidence on the CancerSEEK blood test
Test not ready for use in ovarian cancer screening
Oct 18, 2017
Researchers aim to improve treatment delivery
For years, Dr. Jim Petrik and his lab team at the University of Guelph have focused on improving the quality of tumour blood vessels. While it may sound like this helps the tumour, the approach is showing promise for improved treatment delivery.